Trinity Biotech Mergers & Acquisitions

Trinity Biotech M&A Summary

Trinity Biotech has acquired 9 companies, including 6 in the last 5 years. A total of 2 acquisitions came from private equity firms.

Trinity Biotech’s largest acquisition to date was in 2013, when it acquired IMMCO Diagnostics for $33M. Trinity Biotech has acquired in 4 different US states, and 4 countries. The Company’s most targeted sectors include life science (45%) and medical products (34%).

M&A Summary

  • M&A Total Activity9
    • M&A Buy Activity9
  • Total Sectors Invested 3
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 4

Trinity Biotech

Trinity Biotech Plc

IDA Business Park,
Bray, A98 H5C8
Ireland,
+353 1 276 9800
www.trinitybiotech.com

All (9) Buy (9) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2024-10-25 EpiCapture · Life Science
Dublin, Ireland · www.epicapturedx.com

EpiCapture is a company developing a non-invasive test for monitoring the risk of aggressive prostate cancer. EpiCapture is based in Dublin, Ireland.

3 Add-on Acquisition

Trinity Biotech

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.